Endogenous Interferences in Clinical Laboratory Tests
Icteric, Lipemic and Turbid Samples
Seiten
New Series: Patient Safety Medical errors do not only occur in the laboratory, but pose a direct threat to patient safety. The clinical laboratory is an integral part of care, and the results of analytics are an essential component of informed decision-making for clinicians. Efforts to avoid laboratory errors, especially minimizing pre- and postanalytical errors, are in the responsibility of laboratory professionals.The new handbook series with the international known editors Oswald Sonntag and Mario Plebani fills a vacancy in the relevant and promising area of patient safety and quality assurance.
The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.
The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.
Martin H. Kroll, Boston University, Massachusetts, USA; Christopher R. McCudden, University of Ottawa, Ontario, Canada; University of North Carolina at Chapel Hill, USA.
| Erscheint lt. Verlag | 13.12.2012 |
|---|---|
| Reihe/Serie | Patient Safety ; 5 |
| Zusatzinfo | 28 b/w ill., 19 b/w tbl. |
| Verlagsort | Berlin/Boston |
| Sprache | englisch |
| Maße | 170 x 240 mm |
| Gewicht | 312 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Laboratoriumsmedizin |
| Studium ► 2. Studienabschnitt (Klinik) ► Pathologie | |
| Schlagworte | Behandlungsfehler • Bilirubinemia • Clinical Pathology • Interference • Interference; Bilirubinemia; Lipemia; Clinical Pathology; Patient Safety • Interferenz • Klinische Pathologie • Labormedizin • Lipemia • Patientensicherheit • patient safety |
| ISBN-10 | 3-11-026620-2 / 3110266202 |
| ISBN-13 | 978-3-11-026620-7 / 9783110266207 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Klinisch-pathologische Übersichtskarten
Buch | Hardcover (2023)
Springer (Verlag)
CHF 48,95
